- Home
- Publications
- Publication Search
- Publication Details
Title
Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 10, Pages e0140781
Publisher
Public Library of Science (PLoS)
Online
2015-10-24
DOI
10.1371/journal.pone.0140781
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer
- (2015) S. Song et al. CLINICAL CANCER RESEARCH
- A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
- (2015) Toshiro Moroishi et al. GENES & DEVELOPMENT
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- (2015) Luping Lin et al. NATURE GENETICS
- The Hippo Transducer YAP1 Transforms Activated Satellite Cells and Is a Potent Effector of Embryonal Rhabdomyosarcoma Formation
- (2014) Annie M. Tremblay et al. CANCER CELL
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
- (2014) Avnish Kapoor et al. CELL
- KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
- (2014) Diane D. Shao et al. CELL
- Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis
- (2014) A. N. Lau et al. EMBO JOURNAL
- YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors
- (2014) David Fu et al. ENDOCRINE-RELATED CANCER
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- Outcome for Children with Metastatic Solid Tumors over the Last Four Decades
- (2014) Stephanie M. Perkins et al. PLoS One
- YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistance in Ovarian Cancer Initiated Cells
- (2014) Yan Xia et al. PLoS One
- Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
- (2014) J. F. Shern et al. Cancer Discovery
- Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
- (2013) Xiang Chen et al. CANCER CELL
- YAP/TEAD-Mediated Transcription Controls Cellular Senescence
- (2013) Q. Xie et al. CANCER RESEARCH
- Mechanisms of impaired differentiation in rhabdomyosarcoma
- (2013) Charles Keller et al. FEBS Journal
- Alveolar rhabdomyosarcoma–associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression
- (2013) Lisa E.S. Crose et al. JOURNAL OF CLINICAL INVESTIGATION
- Distinct and Overlapping Sarcoma Subtypes Initiated from Muscle Stem and Progenitor Cells
- (2013) Jordan M. Blum et al. Cell Reports
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
- (2013) Ashley R. P. Hinson et al. Frontiers in Oncology
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells
- (2012) R. N. Judson et al. JOURNAL OF CELL SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Inhibition of the Notch-Hey1 Axis Blocks Embryonal Rhabdomyosarcoma Tumorigenesis
- (2011) B. C. Belyea et al. CLINICAL CANCER RESEARCH
- Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways
- (2011) N. Shukla et al. CLINICAL CANCER RESEARCH
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells
- (2011) S. Hettmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Yap is a novel regulator of C2C12 myogenesis
- (2010) Kevin I. Watt et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
- (2010) G. Schaaf et al. CANCER RESEARCH
- YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas
- (2010) Zofia Hélias-Rodzewicz et al. GENES CHROMOSOMES & CANCER
- BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma
- (2010) J H Hsu et al. ONCOGENE
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005
- (2009) Simona Ognjanovic et al. CANCER
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
- (2009) Dawang Zhou et al. CANCER CELL
- Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
- (2008) S. Naini et al. CANCER RESEARCH
- Negative Regulation of YAP by LATS1 Underscores Evolutionary Conservation of the Drosophila Hippo Pathway
- (2008) J. Zhang et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now